- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Purpose Bitcoin ETF
Silver47 Exploration
CI Galaxy Bitcoin ETF
Black Swan Graphene
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Bausch Health Companies To Present Latest Products
Bausch + Lomb, a subsidiary of Bausch Health Companies, announced the presentation of 26 new scientific analyses and three posters at the upcoming American Society of Cataract and Refractive Surgery Annual Meeting.
Bausch + Lomb, a subsidiary of Bausch Health Companies (NYSE:BHC,TSX:BHC), announced the presentation of 26 new scientific analyses and three posters at the upcoming American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting.
As quoted in the press release:
“These new scientific presentations reflect the positive experiences that ophthalmic surgeons are having with Bausch + Lomb products, including the Stellaris Elite™ vision enhancement system and enVista intraocular lenses,” said Joe Gordon, U.S. president, Bausch + Lomb. “We are pleased and proud to see so many of our customers and their patients benefiting from our technologies, and grateful for their willingness to share their data, experiences and insights with others attending the ASCRS meeting.”
The company will also hold a number of educational events and its first in-booth #ExperienceExchange where customers will have the opportunity to join internationally recognized surgeons in a one-on-one setting to discuss best practices, learn from the experiences of their peers and get more clinical insight into Bausch + Lomb surgical technologies. These include the Stellaris Elite vision enhancement system for cataract and retina surgery, the VICTUS femtosecond laser for advanced cataract and corneal applications, and its broad selection of intraocular lenses (IOLs) and delivery systems, including the enVista MX60E with StableFlex technology and the enVista toric MX60T.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.